Cargando…
COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective
The COVID‐19 pandemic changed health‐care operations around the world and has interrupted standard clinical practices as well as created clinical research challenges for cancer patients. Cancer patients are uniquely susceptible to COVID‐19 infection and have some of the worst outcomes. Importantly,...
Autores principales: | Marcum, Michelle, Kurtzweil, Nicky, Vollmer, Christine, Schmid, Lisa, Vollmer, Ashley, Kastl, Alison, Acker, Kelly, Gulati, Shuchi, Grover, Punita, Herzog, Thomas J., Ahmad, Syed A., Sohal, Davendra, Wise‐Draper, Trisha M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404529/ https://www.ncbi.nlm.nih.gov/pubmed/32648667 http://dx.doi.org/10.1002/cam4.3292 |
Ejemplares similares
-
Highlights from the American society of hematology conference 2020
por: Grover, Punita, et al.
Publicado: (2021) -
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
por: Crist, McKenzie, et al.
Publicado: (2022) -
A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer
por: Frankart, Andrew J., et al.
Publicado: (2022) -
First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape
por: Gulati, Shuchi, et al.
Publicado: (2022) -
MASTL: A novel therapeutic target for Cancer Malignancy
por: Fatima, Iram, et al.
Publicado: (2020)